Transaction overview
On September 27, 2023, Pymwymic, an impact investment firm based in Great Britain, acquired a significant stake in Vivent, a Swiss-based technology company developing digital crop diagnostics solutions for sustainable agriculture. The deal's value was undisclosed but represented less than 50% ownership of the target company. Vivent offers wearable devices that monitor plant electrophysiology to provide early warnings of disease and stress factors, aiming to optimize growing conditions for higher yields while reducing resource usage.
Deal structure and financing
The exact equity-debt split and the full details of financial arrangements remain undisclosed. Milltrust acted as an advisor on the buy-side for Pymwymic, with no information provided about sell-side advisors or other potential financial intermediaries involved in structuring the deal. No public records indicate any leverage being used to finance the transaction, nor have there been reports of seller-retained equity stakes or lock-up commitments. Additionally, no terms regarding IPO optionality were disclosed.
Strategic context
Pymwymic's investment in Vivent underscores its commitment to sustainable agriculture and environmental stewardship through innovative technological solutions. With a portfolio focused on projects that align with the United Nations' Sustainable Development Goals, Pymwymic saw significant potential in Vivent’s technology as a means of advancing food security and agricultural efficiency while reducing ecological impact. Meanwhile, Vivent's decision to seek investment from Pymwymic indicates its desire to leverage a partner committed to environmental sustainability for strategic growth and market expansion.
Vivent co-founder Carrol Plummer highlighted the deal as an opportunity to accelerate their product development and market reach. The company seeks to expand into new agricultural sectors and further refine its crop health solutions, which are currently in use across Europe and North America, particularly in greenhouses and indoor farms but also increasingly for field-grown crops like potatoes and sugar beets.
Regulatory path
No regulatory scrutiny or approval requirements have been reported for this transaction as of the announcement date. Given the nature of the investment and the fact that it involves less than 50% ownership stake, it is likely that the deal did not trigger mandatory filing obligations under the Hart-Scott-Rodino Act in the United States or EU Merger Regulation guidelines. The primary jurisdictions involved are Switzerland where Vivent is headquartered and Great Britain, where Pymwymic operates from. However, without specific disclosure of regulatory filings, it remains unclear if any national competition authorities reviewed this investment deal for potential anti-competitive concerns.